JP Morgan Chase’s Picard Medical PMI Stock Holding History

JP Morgan Chase’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41	Closed	-$2.19K	–	8219
2026 Q1	$2.19K	Buy	41 +1	+3%	+$72	﹤0.01%	7001
2025 Q4	$3.46K	Buy	+40	New	+$9.41K	﹤0.01%	6869

Other funds holding PMI

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

JP Morgan Chase's PMI Position: Q2 2026 in Review

JP Morgan Chase sold out of Picard Medical (PMI) in Q2 2026, closing a stake of 41 shares — an estimated $2.19K sold.

JP Morgan Chase first reported a position in PMI in Q4 2025 and held it in 2 quarters. The position peaked at $3.46K in Q4 2025. 34 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

JP Morgan Chase reported no remaining Picard Medical position as of Q2 2026 after selling out during the quarter.
JP Morgan Chase sold 41 Picard Medical shares in Q2 2026, an estimated $2.19K.
JP Morgan Chase first reported a position in Picard Medical in Q4 2025 and held it in 2 quarters.
JP Morgan Chase's Picard Medical position peaked at $3.46K in Q4 2025.
34 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.